Histologic subtypes of ovarian carcinoma: an overview

RA Soslow - International Journal of Gynecological Pathology, 2008 - journals.lww.com
Reproducible subclassification of ovarian carcinomas is biologically and increasingly
therapeutically important. The traditional morphologic approach that ignores genotype and …

Mismatch repair deficiency in ovarian cancer—Molecular characteristics and clinical implications

X Xiao, DW Melton, C Gourley - Gynecologic oncology, 2014 - Elsevier
DNA mismatch repair (MMR) deficiency is associated with increased risk of developing
several types of cancer and is the most common cause of hereditary ovarian cancer after …

Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the …

MA Murphy, N Wentzensen - International Journal of Cancer, 2011 - Wiley Online Library
Loss of mismatch repair (MMR) capacity may represent an important tumor initiating
mechanism in ovarian cancer. We conducted a systematic review to analyze the frequency …

Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer

X Xiao, D Dong, W He, L Song, Q Wang, J Yue… - Gynecologic …, 2018 - Elsevier
Objective The role of mismatch repair (MMR) deficiency in ovarian cancer (OC)
pathogenesis and its association with other clinicopathologic features, such as microsatellite …

A review of the clinical relevance of mismatch‐repair deficiency in ovarian cancer

T Pal, J Permuth‐Wey, TA Sellers - … International Journal of the …, 2008 - Wiley Online Library
Ovarian cancer ranks fifth in both cancer incidence and mortality among women in the
United States. Defects in the mismatch‐repair (MMR) pathway that arise through genetic …

Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry

J Shia, S Holck, G DePetris, JK Greenson, DS Klimstra - Familial Cancer, 2013 - Springer
It was a century ago that Warthin, a pathologist, first described the clinical condition now
known as Lynch syndrome. One hundred years later, our understanding of this syndrome …

Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary

KR Vierkoetter, AR Ayabe, M VanDrunen, HJ Ahn… - Gynecologic …, 2014 - Elsevier
Abstract Objective Patients with Lynch Syndrome are at an increased risk for a variety of
malignancies, including ovarian cancer. Ovarian cancers associated with Lynch Syndrome …

High homogeneity of MMR deficiency in ovarian cancer

C Fraune, J Rosebrock, R Simon, C Hube-Magg… - Gynecologic …, 2020 - Elsevier
Objective Mismatch repair (MMR) deficiency and Bethesda panel microsatellite instability
(MSI) are increasingly analyzed to identify tumors that might benefit from immune checkpoint …

Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects …

A Aysal, A Karnezis, I Medhi, JP Grenert… - The American journal …, 2012 - journals.lww.com
A subset of women with uterine cancer exhibiting defective mismatch repair (MMR) proteins
and microsatellite instability (MSI) may have Lynch syndrome, which also confers a risk for …

Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger

KC Jensen, MR Mariappan, GV Putcha… - The American journal …, 2008 - journals.lww.com
Ovarian malignancies occurring in the setting of hereditary nonpolyposis colorectal
carcinoma syndrome typically present in young women, often as the first or “sentinel” cancer …